Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1938]
News [3134]
Articles [127]
Editorials [3]
Conferences [120]
elearning [13]
Evaluating efficacy of denosumab compared with zoledronic acid in symptomatic...
Dr Noopar Raje - Massachusetts General Hospital, Boston, USA
Evaluating efficacy of denosumab compared with zoledronic acid in symptomatic myeloma ( Dr Noopar Raje - Massachusetts General Hospital, Boston, USA )
4 Mar 2017
Long term effects of myeloma treatment
Monica Morris - Myeloma UK, Edinburgh, UK
Long term effects of myeloma treatment ( Monica Morris - Myeloma UK, Edinburgh, UK )
3 Mar 2017
Update on CASTOR trial: Daratumumab, bortezomib, and dexamethasone for relapsed...
Dr Suzanne Lentzsch - Columbia University, New York, USA
Update on CASTOR trial: Daratumumab, bortezomib, and dexamethasone for relapsed or refractory myeloma ( Dr Suzanne Lentzsch - Columbia University, New York, USA )
3 Mar 2017
Caring for multiple myeloma carers
Monica Morris - Myeloma UK, Edinburgh, UK
Caring for multiple myeloma carers ( Monica Morris - Myeloma UK, Edinburgh, UK )
3 Mar 2017
Impact of recurrent myeloma alterations on drug response
Dr Muntasir Mamun Majumder - University of Helsinki, Helsinki, Finland
Impact of recurrent myeloma alterations on drug response ( Dr Muntasir Mamun Majumder - University of Helsinki, Helsinki, Finland )
3 Mar 2017
What is the biology behind immunotherapy for MM?
Dr Alexander Lesokhin - Memorial Sloan Kettering Cancer Center, New York, USA
What is the biology behind immunotherapy for MM? ( Dr Alexander Lesokhin - Memorial Sloan Kettering Cancer Center, New York, USA )
3 Mar 2017
Evolving role of MRD negativity in multiple myeloma
Prof Jesús San Miguel - University Hospital, Salamanca, Spain
Evolving role of MRD negativity in multiple myeloma ( Prof Jesús San Miguel - University Hospital, Salamanca, Spain )
3 Mar 2017
Role of immunotherapy and precision medicines in multiple myeloma and key new...
Prof Sagar Lonial - Emory University, Atlanta, USA
Role of immunotherapy and precision medicines in multiple myeloma and key new guidelines ( Prof Sagar Lonial - Emory University, Atlanta, USA )
3 Mar 2017
Carfilzomib, cyclophosphamide, and dexamethasone in newly diagnosed multiple...
Dr Ralph Boccia - Center for Cancer and Blood Disorders, Bethesda, USA
Carfilzomib, cyclophosphamide, and dexamethasone in newly diagnosed multiple myeloma ( Dr Ralph Boccia - Center for Cancer and Blood Disorders, Bethesda, USA )
3 Mar 2017
Is precision myeloma medicine more hype than reality?
Dr Suzanne Lentzsch - Columbia University, New York, USA
Is precision myeloma medicine more hype than reality? ( Dr Suzanne Lentzsch - Columbia University, New York, USA )
3 Mar 2017
Asia-Pacific approaches to myeloma trials
Prof Chng Wee Joo - National University Health System, Singapore, Singapore
Asia-Pacific approaches to myeloma trials ( Prof Chng Wee Joo - National University Health System, Singapore, Singapore )
3 Mar 2017
Denosumab vs zoledronic acid for bone disease in newly diagnosed multiple...
Prof Evangelos Terpos - University of Athens School of Medicine, Athens, Greece
Denosumab vs zoledronic acid for bone disease in newly diagnosed multiple myeloma ( Prof Evangelos Terpos - University of Athens School of Medicine, Athens, Greece )
3 Mar 2017

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation